Pharmacogenetics Committee

	Chair Vincent Haufroid Brussels, Belgium	Contact Us Scientific Committees Pharmacogenetics Committee
	Vice-Chair Nicholas Picard Limoges, France

Background & Purpose of the Committee

• To promote the knowledge about clinically relevant DNA testing to optimize drug therapy
• To enhance the translation of research into clinical practice
• To encourage discussions on the clinical relevance of specific pharmacogenetics tests, to encourage research into clinically important areas with respect to drug treatment
• To encourage interaction between pharmacologist and toxicologist to promote “toxicogenetics”

Committee Initiatives for 2016/2017

• Develop educational materials for PGx
• Prepare first guideline manuscript
• Interact/represent IATDMCT in international PGx activities
• Perfom survey on PGx clinical use among IATDMCT members

Committee Initiatives Completed in 2014/2015

• Informed members of IATDMCT on current discussions regarding PGx testing, on new potentially interesting pharmacogenetic markers, and the emergence of new technologies.
• Represented IATDMCT in  IFCC, AACC, EFLM, IUPHAR and ESPT for initiatives on PGx.
• Advised IATDMCT Rotterdam committee on scientific program regarding PGx

Additional Committee Resources

Coming Soon!
This section will be updated during the 2016 second phase website redesign.